Cramer’s lightning round: Enbridge is a buy


Loading chart…

Blackline Inc: “They’re losing money. … We can just not go with it.”

Loading chart…

Enbridge Inc: “That is exactly what you should be buying.”

Loading chart…

AxoGen Inc: “It’s a medical device, and I think you have to stick with tried and true. .. Johnson & Johnson.”

Loading chart…

MetLife Inc: “I’m going to have to say yes to that, even as I’m not a great fan of the insurers. … That is too cheap a stock.”

Loading chart…

Bridge Investment Group Holdings: “We don’t really know what they do. … Pass, because there’s too much room for error.”

Loading chart…

Farfetch Ltd: “I say, buy Target down here.”

Disclosure: Cramer’s Charitable Trust owns shares of Johnson & Johnson.

Sign up now for the CNBC Investing Club to follow Jim Cramer’s every move in the market.


Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer’s world? Hit him up!
Mad Money TwitterJim Cramer TwitterFacebookInstagram

Questions, comments, suggestions for the “Mad Money” website?

Articles You May Like

Hawaii Home Rented By Justin Bieber At $10,000 A Night Is Going Up For Auction
SpaceX raises another $250 million in equity, lifts total to $2 billion in 2022
Fed Governor Bowman sees ‘similarly sized’ rate hikes ahead after three-quarter point moves
Democrats’ Bill Would Allow Auto Dealers To Claim Clean Vehicle Tax Credits
Reconciliation bill includes nearly $80 billion for IRS including enforcement, audits: What that means for taxpayers

Leave a Reply

Your email address will not be published.